AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Sponsored Reports
Loading...
| Previous Close (in USD) | -- |
|---|---|
| Change | 0.000 0.000% |
| 52 W H/L (in USD) | 3.970/1.140 |
| EBITDA (in USD) | -7.28M |
| PE Ratio | -- |
| Volume | -- |
| Diluted Eps TTM | -0.19 |
| Total Assets (in USD) | 41.418M |
|---|---|
| Total Liabilities (in USD) | 8.001M |
| Revenue TTM (in USD) | 17.318M |
| Cash (in USD) | 21.67M |
| Market Cap (in USD) | 40.606 M |
| Revenue Per Share TTM | 0.676 |
| Gross Profit TTM (in USD) | 20.109M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
icad inc
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Employees: 67
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Ms. Stacey M. Stevens | Pres, CEO & Director | 1968 |
| 2. | Mr. Jonathan Go | Chief Technology Officer | 1963 |
| 3. | Mr. Michael S. Klein | Exec. Director | 1954 |
| 4. | Mr. Stephen P. Sarno | Interim Chief Financial Officer | 1967 |
| 5. | Ms. Annette L. Heroux | VP of Admin. | 1957 |
| 6. | Mr. Anthony Takazawa | Director of Investor Relations | NA |
| 7. | Brian Testa | Chief People Officer | NA |
| 8. | Mr. Jeffrey Sirek | Chief Commercial Officer | NA |
| 9. | Ms. Dana R. Brown | President, CEO & Executive Chair | 1965 |
| 10. | Mr. Eric Lonnqvist | Chief Financial Officer | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
-0.090 0.102% | 88.64 | 25.970 | 17.241 | 3.570 | 3.200 | 3.805 | 16.753 |
|
SYK
Stryker Corporation |
+6.660 2.212% | 301.19 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
+1.200 1.536% | 78.59 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+0.340 0.756% | 45.06 | 31.490 | 17.241 | 4.407 | 3.650 | 4.878 | 19.194 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -13.772M | -11.244M | -17.572M | -13.508M | -8.975M |
| Minority Interest | - | - | - | - | - |
| Net Income | -13.656M | -11.245M | -17.61M | -13.551M | -9.017M |
| Selling General Administrative | 11.234M | 10.406M | 9.117M | 7.443M | 9.117M |
| Gross Profit | 19.812M | 24.243M | 21.354M | 24.227M | 19.43M |
| Reconciled Depreciation | 0.521M | 0.557M | 0.577M | 0.674M | 0.708M |
| Ebit | -13.93M | -10.732M | -9.388M | -6.397M | -8.471M |
| Ebitda | -13.241M | -10.16M | -16.178M | -12.05M | -7.763M |
| Depreciation And Amortization | 0.689M | 0.572M | -6.79M | -5.653M | 0.708M |
| Operating Income | -13.93M | -10.732M | -9.388M | -6.397M | -8.13M |
| Other Operating Expenses | 41.874M | 44.37M | 39.086M | 37.737M | 33.751M |
| Interest Expense | 0.01M | 0.141M | 0.476M | 0.784M | 0.504M |
| Tax Provision | -0.116M | 0.001M | 0.038M | 0.043M | 0.042M |
| Interest Income | 0.213M | 0.015M | 0.097M | 0.344M | 0.11M |
| Net Interest Income | 0.203M | -0.141M | -0.476M | -0.44M | -0.845M |
| Income Tax Expense | -0.116M | 0.001M | 0.038M | 0.043M | 0.042M |
| Total Revenue | 27.944M | 33.638M | 29.698M | 31.34M | 25.621M |
| Total Operating Expenses | 33.742M | 34.975M | 30.742M | 30.624M | 27.56M |
| Cost Of Revenue | 8.132M | 9.395M | 8.344M | 7.113M | 6.191M |
| Total Other Income Expense Net | 0.158M | -0.512M | -8.184M | -7.111M | 0.11M |
| Net Income From Continuing Ops | -13.656M | -11.245M | -17.61M | -13.551M | -9.017M |
| Net Income Applicable To Common Shares | -13.656M | -11.245M | -17.61M | -13.551M | -9.017M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 41.418M | 51.705M | 62.191M | 55.582M | 41.748M |
| Intangible Assets | 0.148M | 0.482M | 0.683M | 0.889M | 1.183M |
| Other Current Assets | 0.699M | 2.641M | 2.962M | 1.945M | 1.453M |
| Total Liab | 8.001M | 16.803M | 15.674M | 25.057M | 36.677M |
| Total Stockholder Equity | 33.417M | 34.902M | 46.517M | 30.525M | 5.071M |
| Other Current Liab | 2.448M | 4.681M | 5.642M | 7.039M | 6.59M |
| Common Stock | 0.265M | 0.254M | 0.253M | 0.236M | 0.196M |
| Capital Stock | 0.265M | 0.254M | 0.253M | 0.236M | 0.196M |
| Retained Earnings | -271.683M | -266.836M | -253.18M | -241.935M | -224.325M |
| Good Will | 8.362M | 8.362M | 8.362M | 8.362M | 8.362M |
| Other Assets | 0M | 0.185M | 0.899M | 3.285M | 0.05M |
| Cash | 21.67M | 21.313M | 34.282M | 27.186M | 15.313M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 6.748M | 13.452M | 14.962M | 16.751M | 18.836M |
| Current Deferred Revenue | 3.4M | 6.216M | 5.652M | 6.117M | 5.248M |
| Net Debt | -21.209M | -17.928M | -33.127M | -18.425M | 7.177M |
| Short Term Debt | 0.188M | 0.582M | 0.889M | 0.726M | 5.008M |
| Short Long Term Debt | - | - | - | - | 4.25M |
| Short Long Term Debt Total | 0.461M | 3.385M | 1.155M | 8.761M | 22.49M |
| Other Stockholder Equity | 304.835M | 301.484M | 299.444M | 272.224M | 229.2M |
| Property Plant Equipment | - | 4.435M | 1.941M | 2.502M | 0.551M |
| Total Current Assets | 29.678M | 38.241M | 50.306M | 42.302M | 29.196M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 6.392M | 8.898M | 8.891M | 10.027M | 9.819M |
| Long Term Debt | - | - | - | 6.96M | 2.003M |
| Inventory | 0.917M | 5.389M | 4.171M | 3.144M | 2.611M |
| Accounts Payable | 0.712M | 1.973M | 2.779M | 2.869M | 1.99M |
| Accumulated Other Comprehensive Income | 0M | - | - | - | -6.51M |
| Non Currrent Assets Other | 0.692M | 0.069M | 0.899M | 1.527M | 0.05M |
| Non Current Assets Total | 11.74M | 13.464M | 11.885M | 13.28M | 12.552M |
| Capital Lease Obligations | 0.461M | 3.385M | 1.155M | 1.801M | 1.837M |
| Long Term Debt Total | - | - | - | - | 3.84M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Investments | -0.844M | -0.534M | -0.587M | -0.474M | -0.306M |
| Total Cashflows From Investing Activities | - | -0.534M | -0.587M | -0.474M | -0.306M |
| Total Cash From Financing Activities | 2.046M | 0.355M | 17.091M | 19.332M | 10.541M |
| Net Income | -7.01M | -13.656M | -11.245M | -17.61M | -13.551M |
| Change In Cash | 0.357M | -12.969M | 7.096M | 11.873M | 3.128M |
| Begin Period Cash Flow | 21.313M | 34.282M | 27.186M | 15.313M | 12.185M |
| End Period Cash Flow | 21.67M | 21.313M | 34.282M | 27.186M | 15.313M |
| Total Cash From Operating Activities | -4.964M | -12.789M | -9.408M | -6.985M | -7.107M |
| Depreciation | 0.409M | 0.521M | 0.557M | 0.577M | 0.674M |
| Other Cashflows From Investing Activities | - | - | -0.024M | - | -0.01M |
| Dividends Paid | - | - | 0.059M | 0.266M | 0.196M |
| Change To Inventory | 1.489M | -1.218M | -1.027M | -0.533M | -1.024M |
| Sale Purchase Of Stock | - | 0.148M | -0.059M | 0.266M | -0.196M |
| Other Cashflows From Financing Activities | 0M | 0.355M | -0.059M | 8.46M | 3.599M |
| Capital Expenditures | 1.264M | 0.534M | 0.587M | 0.474M | 0.306M |
| Change In Working Capital | 0.092M | -2.674M | -2.171M | -0.774M | -2.282M |
| Other Non Cash Items | 0.209M | 1.45M | 0.667M | 7.977M | 6.882M |
| Free Cash Flow | -6.228M | -13.323M | -9.995M | -7.459M | -7.413M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Total Stock Mkt Idx Inv | 2 years ago | 726680 |
| 2. | Strategic Advisers Small-Mid Cap | 2 years ago | 678124 |
| 3. | First Eagle US Small Cap Strategy | 2 years ago | 637491 |
| 4. | First Eagle Small Cap Opportunity I | 2 years ago | 637491 |
| 5. | Vanguard Institutional Extnd Mkt Idx Tr | 2 years ago | 319228 |
| 6. | PSM Value Strategy UI | 2 years ago | 210395 |
| 7. | PSM Macro Strategy | 2 years ago | 190000 |
| 8. | Fidelity Extended Market Index | 2 years ago | 133376 |
| 9. | PSM Konzept | 2 years ago | 118770 |
| 10. | GCA SMID Cap Equity | 2 years ago | 111206 |
| 11. | Perritt MicroCap Opportunities Investor | 2 years ago | 110000 |
| 12. | Bridgeway Ultra-Small Company | 2 years ago | 74600 |
| 13. | iShares Micro-Cap ETF | 2 years ago | 52138 |
| 14. | BlackRock Extended Mkt Composite | 2 years ago | 45331 |
| 15. | BlackRock Extended Equity Market K | 2 years ago | 39562 |
| 16. | Fidelity Series Total Market Index | 2 years ago | 35050 |
| 17. | Fidelity Total Market Index | 2 years ago | 34593 |
| 18. | M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc | 2 years ago | 33299 |
| 19. | Fidelity Nasdaq Composite Index | 2 years ago | 25911 |
| 20. | PSM Dynamik | 2 years ago | 25621 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Portolan Capital Management, LLC | 2 years ago | 1208266 |
| 2. | Vanguard Group Inc | 2 years ago | 1087355 |
| 3. | Arnhold & S. Bleichroeder Advisers, LLC | 2 years ago | 701525 |
| 4. | Renaissance Technologies Corp | 2 years ago | 522190 |
| 5. | BlackRock Inc | 2 years ago | 348102 |
| 6. | Greenwood Capital Associates, LLC | 2 years ago | 322035 |
| 7. | Geode Capital Management, LLC | 2 years ago | 239376 |
| 8. | General American Investors Company Inc | 2 years ago | 200434 |
| 9. | Deutsche Bank AG | 2 years ago | 173787 |
| 10. | Goss Wealth Management LLC | 2 years ago | 162731 |
| 11. | Perritt Capital Management Inc. | 2 years ago | 139983 |
| 12. | AMH Equity Ltd | 2 years ago | 128800 |
| 13. | Squarepoint Ops LLC | 2 years ago | 96003 |
| 14. | Morgan Stanley - Brokerage Accounts | 2 years ago | 84834 |
| 15. | Bridgeway Capital Management, LLC | 2 years ago | 74600 |
| 16. | Salem Investment Counselors Inc | 2 years ago | 73904 |
| 17. | State Street Corporation | 2 years ago | 72135 |
| 18. | Susquehanna International Group, LLP | 2 years ago | 52831 |
| 19. | Millennium Management LLC | 2 years ago | 50641 |
| 20. | Dimensional Fund Advisors, Inc. | 2 years ago | 50338 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...